COL1A1 and hepatocellular carcinoma: Previous studies on COL1A1 have primarily focused on human diseases and cancers [44], suggesting that the COL1A1 gene may serve as a biomarker and therapeutic target for hepatocellular carcinoma and metastasis [45].